The Cigna Group (NYSE:CI) Upgraded to Strong-Buy at StockNews.com

The Cigna Group (NYSE:CI - Get Free Report) was upgraded by investment analysts at StockNews.com from a "buy" rating to a "strong-buy" rating in a report issued on Tuesday.

CI has been the subject of several other reports. Stephens reduced their price objective on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating for the company in a research report on Friday, January 31st. Cantor Fitzgerald raised their price target on shares of The Cigna Group from $350.00 to $365.00 and gave the stock an "overweight" rating in a research report on Thursday, March 20th. Wells Fargo & Company dropped their price objective on shares of The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a report on Tuesday, February 4th. Oppenheimer reduced their target price on shares of The Cigna Group from $400.00 to $375.00 and set an "outperform" rating for the company in a research note on Friday, January 31st. Finally, Truist Financial lowered their price target on The Cigna Group from $390.00 to $375.00 and set a "buy" rating on the stock in a research note on Tuesday, February 4th. Two equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $375.00.

Remove Ads

The Cigna Group Stock Up 0.7 %

Shares of NYSE CI traded up $2.25 during mid-day trading on Tuesday, reaching $329.52. 1,727,459 shares of the company traded hands, compared to its average volume of 1,689,887. The company's fifty day moving average is $312.04 and its two-hundred day moving average is $311.31. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The stock has a market cap of $90.18 billion, a PE ratio of 26.92, a price-to-earnings-growth ratio of 0.98 and a beta of 0.51.

The Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter last year, the firm earned $6.79 earnings per share. On average, analysts expect that The Cigna Group will post 29.77 earnings per share for the current year.

Insider Transactions at The Cigna Group

In other The Cigna Group news, Director Elder Granger sold 2,376 shares of the firm's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $310.35, for a total value of $737,391.60. Following the completion of the sale, the director now owns 5,471 shares in the company, valued at approximately $1,697,924.85. This trade represents a 30.28 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO David Cordani sold 26,527 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the transaction, the chief executive officer now owns 127,767 shares in the company, valued at $39,367,568.04. The trade was a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 43,751 shares of company stock valued at $13,603,991. Corporate insiders own 0.70% of the company's stock.

Institutional Trading of The Cigna Group

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Moody National Bank Trust Division raised its holdings in The Cigna Group by 0.7% during the 1st quarter. Moody National Bank Trust Division now owns 4,587 shares of the health services provider's stock worth $1,509,000 after purchasing an additional 34 shares during the last quarter. Kesler Norman & Wride LLC grew its position in shares of The Cigna Group by 1.8% during the 4th quarter. Kesler Norman & Wride LLC now owns 2,033 shares of the health services provider's stock worth $562,000 after buying an additional 35 shares during the period. Hudson Edge Investment Partners Inc. raised its stake in shares of The Cigna Group by 1.9% during the fourth quarter. Hudson Edge Investment Partners Inc. now owns 1,883 shares of the health services provider's stock worth $520,000 after buying an additional 36 shares during the last quarter. Fifth Third Wealth Advisors LLC lifted its holdings in The Cigna Group by 2.3% in the first quarter. Fifth Third Wealth Advisors LLC now owns 1,626 shares of the health services provider's stock valued at $535,000 after buying an additional 36 shares during the period. Finally, Meridian Wealth Management LLC lifted its holdings in The Cigna Group by 1.0% in the fourth quarter. Meridian Wealth Management LLC now owns 3,670 shares of the health services provider's stock valued at $1,013,000 after buying an additional 37 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.